These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

618 related items for PubMed ID: 25095501

  • 1. Clinical strategy for induction of transplantation tolerance through mixed chimerism.
    Cosimi AB, Sachs DH, Sykes M, Kawai T.
    Clin Transpl; 2013; ():127-34. PubMed ID: 25095501
    [Abstract] [Full Text] [Related]

  • 2. Preclinical and clinical studies for transplant tolerance via the mixed chimerism approach.
    Sasaki H, Oura T, Spitzer TR, Chen YB, Madsen JC, Allan J, Sachs DH, Cosimi AB, Kawai T.
    Hum Immunol; 2018 May; 79(5):258-265. PubMed ID: 29175110
    [Abstract] [Full Text] [Related]

  • 3. Inducing Transient Mixed Chimerism for Allograft Survival Without Maintenance Immunosuppression With Combined Kidney and Bone Marrow Transplantation: Protocol Optimization.
    Lee KW, Park JB, Park H, Kwon Y, Lee JS, Kim KS, Chung YJ, Rhu JS, Choi S, Kwon GY, Kim HJ, Kang ES, Jung CW, Shin EC, Kawai T, Kim SJ, Joh JW.
    Transplantation; 2020 Jul; 104(7):1472-1482. PubMed ID: 31634324
    [Abstract] [Full Text] [Related]

  • 4. Tolerance induction: hematopoietic chimerism.
    Kawai T, Sachs DH.
    Curr Opin Organ Transplant; 2013 Aug; 18(4):402-7. PubMed ID: 23838644
    [Abstract] [Full Text] [Related]

  • 5. Reflections on the unique tolerogenicity of bone marrow, the enigma of chimerism and clinical tolerance.
    Monaco AP.
    Clin Transpl; 2013 Aug; ():157-66. PubMed ID: 25095504
    [Abstract] [Full Text] [Related]

  • 6. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY, Pelot M, Zhao G, Swenson K, Pearson D, Sykes M.
    Biol Blood Marrow Transplant; 2001 Aug; 7(12):646-55. PubMed ID: 11787527
    [Abstract] [Full Text] [Related]

  • 7. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
    Tillson M, Niemeyer GP, Welch JA, Brawner W, Swaim SF, Rynders P, Lenz SD, Dean B, Lothrop CD.
    Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
    [Abstract] [Full Text] [Related]

  • 8. Twenty-year Follow-up of Histocompatibility Leukocyte Antigen-matched Kidney and Bone Marrow Cotransplantation for Multiple Myeloma With End-stage Renal Disease: Lessons Learned.
    Spitzer TR, Tolkoff-Rubin N, Cosimi AB, McAfee S, Dey BR, Chen YB, Delmonico F, Sykes M, Sachs DH, Kawai T.
    Transplantation; 2019 Nov; 103(11):2366-2372. PubMed ID: 30801529
    [Abstract] [Full Text] [Related]

  • 9. HLA identical non-chimeric and HLA disparate chimeric renal transplant tolerance.
    Leventhal JR, Mathew JM, Ildstad S, Salomon DR, Kurian SM, Suthanthiran M, Tambur A, Friedewald J, Gallon L, Charette J, Levitsky J, Kanwar Y, Abecassis M, Miller J.
    Clin Transpl; 2013 Nov; ():145-56. PubMed ID: 25095503
    [Abstract] [Full Text] [Related]

  • 10. Effect of Ex Vivo-Expanded Recipient Regulatory T Cells on Hematopoietic Chimerism and Kidney Allograft Tolerance Across MHC Barriers in Cynomolgus Macaques.
    Duran-Struuck R, Sondermeijer HP, Bühler L, Alonso-Guallart P, Zitsman J, Kato Y, Wu A, McMurchy AN, Woodland D, Griesemer A, Martinez M, Boskovic S, Kawai T, Cosimi AB, Yang YG, Hu Z, Wuu CS, Slate A, Mapara M, Baker S, Tokarz R, D'Agati V, Hammer S, Pereira M, Lipkin WI, Wekerle T, Levings M, Sykes M.
    Transplantation; 2017 Feb; 101(2):274-283. PubMed ID: 27846155
    [Abstract] [Full Text] [Related]

  • 11. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V, Troisi R, Toungouz M, Colle I, Van Vlierberghe H, Jacquy C, Martiat P, Stordeur P, Zhou L, Boon N, Lambermont M, Schandené L, Van Laethem JL, Noens L, Gelin M, de Hemptinne B, Goldman M.
    Transpl Immunol; 2004 Feb; 13(2):139-46. PubMed ID: 15380544
    [Abstract] [Full Text] [Related]

  • 12. Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression.
    Kawai T, Sachs DH, Sprangers B, Spitzer TR, Saidman SL, Zorn E, Tolkoff-Rubin N, Preffer F, Crisalli K, Gao B, Wong W, Morris H, LoCascio SA, Sayre P, Shonts B, Williams WW, Smith RN, Colvin RB, Sykes M, Cosimi AB.
    Am J Transplant; 2014 Jul; 14(7):1599-611. PubMed ID: 24903438
    [Abstract] [Full Text] [Related]

  • 13. Immune monitoring of transplant patients in transient mixed chimerism tolerance trials.
    Sykes M.
    Hum Immunol; 2018 May; 79(5):334-342. PubMed ID: 29289741
    [Abstract] [Full Text] [Related]

  • 14. Transient-mixed Chimerism With Nonmyeloablative Conditioning Does Not Induce Liver Allograft Tolerance in Nonhuman Primates.
    Chaudhry S, Kato Y, Weiner J, Alonso-Guallart P, Baker S, Woodland DC, Lefkowitch JH, Duran-Struuck R, Sondermeijer HP, Zitsman J, Sears ML, Wu A, Karolewski B, Houck PJ, Martinez M, Kato T, Sykes M, Griesemer AD.
    Transplantation; 2020 Aug; 104(8):1580-1590. PubMed ID: 32732835
    [Abstract] [Full Text] [Related]

  • 15. Long-term Nonhuman Primate Renal Allograft Survival Without Ongoing Immunosuppression in Recipients of Delayed Donor Bone Marrow Transplantation.
    Hotta K, Oura T, Dehnadi A, Boskovic S, Matsunami M, Rosales I, Smith RN, Colvin RB, Cosimi AB, Kawai T.
    Transplantation; 2018 Apr; 102(4):e128-e136. PubMed ID: 29300231
    [Abstract] [Full Text] [Related]

  • 16. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
    Chen B, Xu H, Corbin DR, Ildstad ST.
    Transplantation; 2012 Oct 15; 94(7):671-8. PubMed ID: 22948444
    [Abstract] [Full Text] [Related]

  • 17. Preclinical and clinical studies on the induction of renal allograft tolerance through transient mixed chimerism.
    Kawai T, Cosimi AB, Sachs DH.
    Curr Opin Organ Transplant; 2011 Aug 15; 16(4):366-71. PubMed ID: 21666482
    [Abstract] [Full Text] [Related]

  • 18. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil.
    Niemeyer GP, Welch JA, Tillson M, Brawner W, Rynders P, Goodman S, Dufresne M, Dennis J, Lothrop CD.
    Transplant Proc; 2005 Dec 15; 37(10):4579-86. PubMed ID: 16387175
    [Abstract] [Full Text] [Related]

  • 19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 15; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 20. Monitoring antidonor alloantibodies as a predictive assay for renal allograft tolerance/long-term observations in nonhuman primates.
    Boskovic S, Kawai T, Smith RN, Wee SL, Nadazdin O, Koyama I, Saidman S, Cardarelli F, Elias N, Sykes M, Strom T, Colvin RB, Sachs DH, Cosimi AB.
    Transplantation; 2006 Sep 27; 82(6):819-25. PubMed ID: 17006330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.